Naveen Pemmaraju, Professor and Director of the BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center, shared a paper he and his colleagues authored on X:
“Honored to be a part of this important international effort led by Dr. Nicola Polverelli.
Role of allo-HCT in nonclassical MPNs and MDS/MPNs: recommendations from the PH/G Committee and the CMWP of the EBMT.”
Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute and Atrium Health Wake Forest Baptist Comprehensive Cancer Center, shared this post, adding:
“Honored to join colleagues on this important discussion regarding BMT/SCT and Myelofibrosis.”
Authors: Nicola Polverelli et al.
